The Human antigen R (HuR) protein is an RNA-binding protein, ubiquitously expressed in human tissues, that orchestrates target RNA maturation and processing both in the nucleus and in the cytoplasm. A survey of known modulators of the RNA-HuR interactions is followed by a description of its structure and molecular mechanism of action - RRM domains, interactions with RNA, dimerization, binding modes with naturally occurring and synthetic HuR inhibitors. Then, the review focuses on HuR as a validated molecular target in oncology and briefly describes its role in inflammation. Namely, we show ample evidence for the involvement of HuR in the hallmarks and enabling characteristics of cancer, reporting findings from in vitro and in vivo studies; and we provide abundant experimental proofs of a beneficial role for the inhibition of HuR-mRNA interactions through silencing (CRISPR, siRNA) or pharmacological inhibition (small molecule HuR inhibitors).

HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer models / Assoni, Giulia; La Pietra, Valeria; Digilio, Rosangela; Ciani, Caterina; Licata, Nausicaa Valentina; Micaelli, Mariachiara; Facen, Elisa; Tomaszewska, Weronika; Cerofolini, Linda; Pérez-Ràfols, Anna; Varela Rey, Marta; Fragai, Marco; Woodhoo, Ashwin; Marinelli, Luciana; Arosio, Daniela; Bonomo, Isabelle; Provenzani, Alessandro; Seneci, Pierfausto. - In: ADVANCED DRUG DELIVERY REVIEWS. - ISSN 0169-409X. - STAMPA. - 181:(2022), pp. 114088-114115. [10.1016/j.addr.2021.114088]

HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer models

Cerofolini, Linda;Pérez-Ràfols, Anna;Fragai, Marco;
2022

Abstract

The Human antigen R (HuR) protein is an RNA-binding protein, ubiquitously expressed in human tissues, that orchestrates target RNA maturation and processing both in the nucleus and in the cytoplasm. A survey of known modulators of the RNA-HuR interactions is followed by a description of its structure and molecular mechanism of action - RRM domains, interactions with RNA, dimerization, binding modes with naturally occurring and synthetic HuR inhibitors. Then, the review focuses on HuR as a validated molecular target in oncology and briefly describes its role in inflammation. Namely, we show ample evidence for the involvement of HuR in the hallmarks and enabling characteristics of cancer, reporting findings from in vitro and in vivo studies; and we provide abundant experimental proofs of a beneficial role for the inhibition of HuR-mRNA interactions through silencing (CRISPR, siRNA) or pharmacological inhibition (small molecule HuR inhibitors).
181
114088
114115
Assoni, Giulia; La Pietra, Valeria; Digilio, Rosangela; Ciani, Caterina; Licata, Nausicaa Valentina; Micaelli, Mariachiara; Facen, Elisa; Tomaszewska, Weronika; Cerofolini, Linda; Pérez-Ràfols, Anna; Varela Rey, Marta; Fragai, Marco; Woodhoo, Ashwin; Marinelli, Luciana; Arosio, Daniela; Bonomo, Isabelle; Provenzani, Alessandro; Seneci, Pierfausto
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0169409X21004816-main.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Dimensione 3.83 MB
Formato Adobe PDF
3.83 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2158/1278501
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact